Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 14.09B
December 31, 2025 14.26B
September 30, 2025 14.46B
June 30, 2025 14.27B
March 31, 2025 13.70B
December 31, 2024 13.25B
September 30, 2024 13.71B
June 30, 2024 14.99B
March 31, 2024 14.94B
December 31, 2023 14.89B
September 30, 2023 14.29B
June 30, 2023 14.40B
March 31, 2023 14.31B
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021 10.51B
December 31, 2020 10.45B
September 30, 2020 10.01B
June 30, 2020 9.598B
March 31, 2020 9.535B
Date Value
December 31, 2019 9.749B
September 30, 2019 9.534B
June 30, 2019 9.596B
March 31, 2019 9.555B
December 31, 2018 8.881B
September 30, 2018 8.865B
June 30, 2018 8.699B
March 31, 2018 8.812B
December 31, 2017 8.735B
September 30, 2017 8.774B
June 30, 2017 8.577B
March 31, 2017 8.440B
December 31, 2016 6.739B
September 30, 2016 6.769B
June 30, 2016 6.793B
March 31, 2016 6.756B
December 31, 2015 6.830B
September 30, 2015 6.655B
June 30, 2015 6.694B
March 31, 2015 6.686B
December 31, 2014 6.994B
September 30, 2014 7.028B
June 30, 2014 6.888B
March 31, 2014 6.847B
December 31, 2013 5.135B

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc 196.35M
Cellectis SA 229.27M
Autolus Therapeutics Plc 418.24M
Akari Therapeutics Plc 19.51M
Evaxion AS 10.43M

Total Liabilities (Quarterly) Related Metrics